Dr. Sarah Elizabeth Squire, MD

Dr. Squire practices at Piedmont Radiation Oncologists, PA in Charlotte, North Carolina.

Dr. Squire's NPI, 1417136185, was assigned on October 30, 2007. Dr. Squire graduated from Warren Alpert Medical School of Brown University in 2006. Dr. Squire holds North Carolina license 2011-00367.

Dr. Squire's primary practice is Piedmont Radiation Oncologists, PA, at 200 Queens Rd, Charlotte, NC 28204 in Mecklenburg County. The practice phone is (336) 832-1100.

Dr. Squire's primary practice is Piedmont Radiation Oncologists, PA in Charlotte, North Carolina. Dr. Squire is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Piedmont Radiation Oncology at Cone Health Cancer Center. Dmand AI also links Dr. Squire to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Squire practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Squire's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Squire is licensed in North Carolina.

CMS data shows 906 Medicare services from Dr. Squire across 14 procedure codes in 2024, for 126 Medicare patients. Medicare paid $64,351 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Squire in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Squire's median patient age at 70, with 56% women.

In 2024, Dr. Squire wrote 173 Medicare Part D claims for 61 patients. 95% of them were for generic drugs. CMS names the drug for 118 of them, across 4 drugs with 11 or more claims each, at $1,859 in total drug cost. In 2023, CMS named 83 claims across 2 drugs.

Dr. Squire accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Squire, published from 2006 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Muscular Dystrophy, Duchenne, Utrophin and Mice, Inbred mdx. Dr. Squire has published most often in Hum Mol Genet. Dr. Squire's most frequent co-authors are Philip David Charles, MD and Karen J. Marcus, MD.

CMS Open Payments shows 26 general payments to Dr. Squire from 20 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $143.

Dr. Squire graduated from Warren Alpert Medical School of Brown University in 2006.